Compartmentalisation of cAMP-dependent signalling in blood platelets: The role of lipid rafts and actin polymerisation

References

• Jackson SP, Dc W. The growing complexity of platelet aggregation. Blood 2007;109:5087–5095
   PubMed Web of Science ®Google Scholar
• Schwarz UR, Walter U, Eigenthaler M. Taming platelets with cyclic nucleotides. Biochem Pharmacol 2001;62:1153–1161
   PubMed Web of Science ®Google Scholar
• Hanoune J, Defer N. Regulation and role of a denylyl. Annu Rev Pharmacol Toxicol 2001;41:145–174
   PubMed Web of Science ®Google Scholar
• Gorman RR, Bunting S, Miller OV. Modulation od human platelet adenylate cyclase by prostacyclin (PGX). Prostaglandins 1977;13:377–388
   PubMed Web of Science ®Google Scholar
• Quinton TM, Dean WL. Cyclic AMP-dependent phosphorylation of the inositol-1,4,5-trisphosphate receptor inhibits Ca2+ release from platelet membranes. Biochem Biophys Res Commun 1992;184:893–899
   PubMed Web of Science ®Google Scholar
• Grabers SE, Hawiger J. Evidence Tht changes in platelet cyclic AMP levels regulate the fibrinogen receptot on human platelets. J Biol Chem 1982;257:14606–14609
   PubMedGoogle Scholar
• Pannocchia A, Hardisty RM. Cyclic AMP inhibits platelet activation independently of its effects on cytosolic free calcium. Biochem Biophys Res Commun 1985;127:339–345
   PubMedGoogle Scholar
• Salzman EW, Kensler PC, Levine L. Cyclic AMP in human blood platelets – Regulatory role of cAMP in platelet function. Ann New York Acad Sci 1972;201:61–71
   PubMed Web of Science ®Google Scholar
• Sim DS, Merrill-Skoloff G, Furie BC, Furie B, Flaumenhaft R. Initial accumulation of platelets during arterial thrombus formation in vivo is inhibited by elevation of basal cAMP levels. Blood 2004;103:2127–2134
   PubMedGoogle Scholar
• Cheng Y, Austin SC, Rocca B, Koller BH, Coffman TM, Grosser T, Lawson JA, FitzGerald GA. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science 2002;296:539–541
   PubMed Web of Science ®Google Scholar
• Rowley JW, Oler AJ, Tolley ND, Hunter BN, Low EN, Nix DA, Yost CC, Zimmerman GA, Weyrich AS. Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. Blood 2011;118:e101–e111
   PubMed Web of Science ®Google Scholar
• Burkhart JM, Vaudel M, Gambaryan S, Radau S, Walter U, Martens L, Sickmann A, Zahedi RP. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood 2012;120:e73–e82
   PubMed Web of Science ®Google Scholar
• Dessauer CW. Adenylyl cyclase – A-kinase anchoring protein complexes: The next dimension in cAMP signaling. Mol Pharmacol 2009;76:935–941
   PubMed Web of Science ®Google Scholar
• Vang T, Abrahamsen H, Myklebust S, Horejsí V, Taskén K. Combined spatial and enzymatic regulation of Csk by cAMP and protein kinase a inhibits T cell receptor signaling. J Biol Chem 2003;278:17597–17600
   PubMedGoogle Scholar
• Components S, Farquhar MG, Insel PA. Microtubules and actin microfilaments regulate lipid raft/caveolae localization of adenylyl cyclase. J Biol Chem 2006;281:26391–26399
   PubMedGoogle Scholar
• Lee FA, van Lier M, Relou IAM, Foley L, Akkerman J-WN, Heijnen HFG, Farndale RW. Lipid rafts facilitate the interaction of PECAM-1 with the glycoprotein VI-FcR gamma-chain complex in human platelets. J Biol Chem 2006;281:39330–39338
   PubMedGoogle Scholar
• McGregor JL, Poston RN. Lipid-rafts: the missing link that integrates platelet functions? J Thromb Haemost 2003;1:1142–1143
   PubMedGoogle Scholar
• Head BP, Patel HH, Roth DM, Murray F, Swaney JS, Niesman IR, Farquhar MG, Insel PA. Microtubules and actin microfilaments regulate lipid raft/caveolae localization of adenylyl cyclase signaling components. J Biol Chem 2006;281:26391–26399
   PubMed Web of Science ®Google Scholar
• el-Daher SS, Eigenthaler M, Walter U, Furuichi T, Miyawaki A, Mikoshiba K, Kakkar VV, Authi KS. Distribution and activation of cAMP- and cGMP-dependent protein kinases in highly purified human platelet plasma and intracellular membranes. Thromb Haemost 1996;76:1063–1071
   PubMedGoogle Scholar
• Sadana R, Dessauer CW. Physiological roles for G protein-regulated adenylyl cyclase isoforms: insights from knockout and overexpression studies. Neurosignals 2009;17:5–22
   PubMedGoogle Scholar
• Ahmad F, Lindh R, Tang Y, Ruishalme I, Ost A, Sahachartsiri B, Strålfors P, Degerman E, Manganiello VC. Differential regulation of adipocyte PDE3B in distinct membrane compartments by insulin and the beta3-adrenergic receptor agonist CL316243: effects of caveolin-1 knockdown on formation/maintenance of macromolecular signalling complexes. Biochem J 2009;424:399–410
   PubMedGoogle Scholar
• Nilsson R, Ahmad F, Swärd K, Andersson U, Weston M, Manganiello V, Degerman E. Plasma membrane cyclic nucleotide phosphodiesterase 3B (PDE3B) is associated with caveolae in primary adipocytes. Cell Signal 2006;18:1713–1721
   PubMedGoogle Scholar
• Bundey RA, Insel PA. Adenylyl cyclase 6 overexpression decreases the permeability of endothelial monolayers via preferential enhancement of prostacyclin receptor function. Mol Pharmacol 2006;70:1700–1707
   PubMedGoogle Scholar
• Ostrom RS, Liu X, Head BP, Gregorian C, Seasholtz TM, Insel PA. Localization of adenylyl cyclase isoforms and G protein-coupled receptors in vascular smooth muscle cells: expression in caveolin-rich and noncaveolin domains. Mol Pharmacol 2002;62:983–992
   PubMed Web of Science ®Google Scholar
• Jourdan KB, Mason NA, Long L, Philips PG, Wilkins MR, Morrell NW. Characterization of adenylyl cyclase isoforms in rat peripheral pulmonary arteries. Am J Physiol Lung Cell Mol Physiol 2001;280:L1359–L1369
   PubMedGoogle Scholar
• Alousi AA, Jasper JR, Insel PA, Motulsky HJ. Stoichiometry of receptor-Gs-adenylate cyclase interactions. FASEB J 1991;5:2300–2303
   PubMedGoogle Scholar